$ENZC
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive…Read More

$ENZC #NEWS

Virogentics and Enzolytics Refute Misleading Information Being Circulated on Social Media and Other Internet Outlets Biogenesis to be Featured in June Issue of Life Science Review

Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) Enzolytics wants to inform its shareholders that the ownership of the Company’s patented technology is held exclusively in the name of The Zhabilov Trust, with Diana Zhabilov serving as the trustee of the trust. This ownership is verified by a review of the records filed with the USPTO and shown on the USPTO web site http://www.uspto.gov.

$ENZC #BUY #SELL #HOLD